Oestrogen and progesterone receptors in breast cancers are also assessed by IHC from formaldehyde-fixed paraffin-embedded tissues or needle biopsies (e.g., ER/PR pharmDx assay kit, Dako). This evidence concerns the gene PGR and breast carcinoma.